Advertisement

Topics

Fluidigm Licenses CFTR NGS Assay from Baylor Genetics for Use with the Juno System

10:28 EDT 18 Aug 2017 | Speciality Pharma Journal

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a next-generation sequencing (NGS) library prep assay that enables efficient sequencing of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Under the agreement, Fluidigm obtains the rights …

Original Article: Fluidigm Licenses CFTR NGS Assay from Baylor Genetics for Use with the Juno System

NEXT ARTICLE

More From BioPortfolio on "Fluidigm Licenses CFTR NGS Assay from Baylor Genetics for Use with the Juno System"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...